Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

Alopecia areata may be caused by the immune system attacking hair follicles.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Folliculotropic mycosis fungoides can look like alopecia areata.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.